Press releases
Nightingale Health's disease risk detection becomes part of annual health assessments at Barnes Private Practice in London
Nov 06, 2026
Stock exchange release
Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc
Nov 05, 2026
Press releases
Nightingale Health reaches next milestone in the United States: first laboratory developed tests approved by New York State
Nov 05, 2026
Press releases
Nightingale Health's disease risk detection becomes part of a longevity membership at S-Thetics Clinic in the United Kingdom
Nov 04, 2026
Press releases
Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
Nov 02, 2026
Stock exchange release
Inside information: Nightingale Health signs USD 1 million proteomics agreement with Alzheimer's Research UK, for neurodegenerative disease research
Oct 28, 2026
Stock exchange release
Inside information: Nightingale Health signs USD 1 million proteomics agreement with LifeArc, for neurodegenerative disease research
Oct 28, 2026
Press releases
Nightingale Health's disease risk detection becomes part of annual health assessments at The Private GP Group in the United Kingdom
Oct 22, 2026
Oct 05, 2026
Stock exchange release
Nightingale Health’s Annual Report for financial year 2025–2026 has been published
Oct 01, 2026
Stock exchange release
Inside information: Nightingale Health signs USD 6.5 million proteomics agreement with the Michael J. Fox Foundation for neurodegenerative disease research
Sep 30, 2026
Press releases
Nightingale Health's disease risk detection becomes available in Latvia through Professor Skride's Heart Clinic
Sep 29, 2026
Stock exchange release
Conversion of Nightingale Health Plc’s Series A shares to Series B shares
Sep 28, 2026